MD Biosciences Expansion to Increase Capacity in Pre-Clinical Drug Discovery Services and Products for Inflammatory and Neurological Diseases
10/6/2009 9:12:15 AM
ST. PAUL, Minn.--(BUSINESS WIRE)--MD Biosciences (MDB), a contract research organization offering pre-clinical services and products in support of drug discovery for inflammatory and neurological diseases, relocated its U.S. office from 1000 Westgate Dr, St Paul, MN to 2575 University Ave W, St Paul, MN on October 3, 2009. The new location equips MD Biosciences with more lab space, allowing for increased capacity for in vitro services and product development and manufacturing to increase product offering.
comments powered by